| Bacterial: OMV | COVID-19 | Ministry of Health, Welfare and Sport of The Netherlands | Phase I |
| Bacterial: OMV | Whooping Cough | Zhifei Lvzhu Biopharmaceutical Co., Ltd | Pre-clinical |
| Bacterial: OMV | Betacoronavirus | Coalition for Epidemic Preparedness Innovations | Pre-clinical |
| Bacterial: OMV | Meningitis B | Liaoning Chengda Biotechnology Co., Ltd | Pre-clinical |
| Bacterial: OMV | Gonorrhoea | National Institute of Allergy and Infectious Diseases | Pre-clinical |
| | Therapyx Inc. | |
| | CarbX | Pre-clinical |
| Viral: Inactivated | Polio | LG Chem Ltd. | Marketed |
| | SINOVAC Biotech Ltd. | Marketed |
| | Beijing Minhai Biological Technology Co., Ltd. | Marketed |
| Viral: Inactivated | Type 1 Diabetes (Coxsackievirus B) | Provention Bio, Inc. | Phase I |
| Viral: Inactivated | Acute Flaccid Myelitis (EV-D68) | National Institute of Allergy and Infectious Diseases | Phase I |
| | | |
| Conjugation | Haemophilus influenzae Type B | Serum Institute of India PVT. LTD. | Marketed |
| | Biological E Ltd | Marketed |
| | Changchun BCHT Biotechnology Co. | Pre-clinical |
| Conjugation | Shigellosis | Institut Pasteur | Phase I / Phase II |
| Conjugation | Amyotrophic Lateral Sclerosis | German Center for Neurodegenerative Diseases | Pre-clinical |
| E.coli expression | Solid tumors | CimCure | Phase I |
